3 ms·
I've always understood this to have been made on assay grounds that the antibody count post-infection wasn't as usefully high or maintained. as in this: https:
by ggm 5y ago
I've always understood this to have been made on assay grounds that the antibody count post-infection wasn't as usefully high or maintained.
as in this: https://academic.oup.com/cid/article-abstract/73/12/2366/6162856 https://academic.oup.com/cid/article-abstract/73/12/2366/616...
this quote from the abstract is what I think i was told: we recently reported that 61.1% of mild SARS-CoV-2 infected patients became seronegative for IgG anti-N within 6 months after first positive PCR [2]. Anti-spike (S) antibodies, in contrast, remained positive up to 7 months in an estimated 94% of participants.
It just doesn't last long enough to be counted as useful, compared to immunisation. If you think the 6month window has some efficacy at scale I guess you have a basis to disagree, and we'd be in the Linear Optimisation problem space. This is why I have always believed we needed O/R people to help determine why the decisions fall as they do.
- nradov 5y agoThat was never a scientifically valid reason. What matters is cellular immunity, not antibody levels. https://peterattiamd.com/covid-part2/ https://peterattiamd.com/covid-part2/
- JPKab 5y agoNIH study from last week: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824301/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824301/ CDC study from a few weeks ago (scroll down to the line graph in the paper, to see how completely misinformed the public has been): https://www.cdc.gov/mmwr/volumes/71/wr/mm7104e1.htm https://www.cdc.gov/mmwr/volumes/71/wr/mm7104e1.htm Additionally, the "antibody count" is completely ridiculous to use as the primary proxy for immunity. Anyone that knows how the immune system actually works can tell you this. Healthy humans have zero circulating antibodies for most of the viruses that they are already immune to. Otherwise the blood would be filled with them. Cells in the bone marrow are where immune memory resides, and the body manufactures circulating antibodies based on these memory cells.